ADVANCED ENZYME TECHNOLOGIES
|
The Current P/S Ratio of ADVANCED ENZYME TECHNOLOGIES is 5.73.
Share Price | ₹326.4 | Jul 25,2025 |
Market Cap | ₹3,651.9 Cr | |
Sales-TTM | ₹636.9 Cr | TTM-Consolidated Results |
Price/Sales | 5.73x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of ADVANCED ENZYME TECHNOLOGIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹3,651.9 Cr] as on Jul 25,2025
(/) Sales [ ₹636.9 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 5.73x ]
Thus, for ADVANCED ENZYME TECHNOLOGIES , the investors are currently willing to pay '5.73 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ADVANCED ENZYME TECHNOLOGIES !
The chart below summarizes the trend in P/S Ratio of ADVANCED ENZYME TECHNOLOGIES over the last five years.
Historical PS (Price/Sales) ratio chart of ADVANCED ENZYME TECHNOLOGIES
PS Ratio Performance Analysis for ADVANCED ENZYME TECHNOLOGIES
- ADVANCED ENZYME TECHNOLOGIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 5.91x.
- ADVANCED ENZYME TECHNOLOGIES 's operated at median p/e ratio of 5.96x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ADVANCED ENZYME TECHNOLOGIES 's p/e ratio peaked in Mar2021 at 7.68x.
- ADVANCED ENZYME TECHNOLOGIES 's p/e ratio hit its five-year low in Mar2023 of 4.79x.
How does ADVANCED ENZYME TECHNOLOGIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
ADVANCED ENZYME TECHNOLOGIES | 636.9 | 5.73 | 3,651.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.75 | 407,551.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 18.77 | 175,704.0 |
CIPLA LTD | 27,547.6 | 4.49 | 123,675.0 |
TORRENT PHARMACEUTICALS LTD | 11,516.0 | 10.59 | 121,925.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.18 | 106,626.0 |
MANKIND PHARMA LTD | 12,279.3 | 8.74 | 107,363.0 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.23 | 98,278.9 |
LUPIN LTD | 22,707.9 | 3.92 | 89,109.1 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.05 | 65,180.5 |
ABBOTT INDIA LTD | 6,409.2 | 11.20 | 71,761.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ADVANCED ENZYME TECHNOLOGIES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.05x |
Max industry PS | 18.77x |
Median industry PS | 5.73x |
Average industry PS | 7.33x |
You may also like the below Video Courses